Oxford Drug Design raises £ 2.2M to develop AI-based drug discovery program
Biotechnology firm Oxford Drug Design Limited (ODD) has raised 2.2M from existing investors ACF Investors, O2h Ventures, Meltwind Advisory, several Returning Angels and new investors and the US-based R42 Group.
Oxford University has created an artificial intelligence (AI) AI-owned platform for the discovery of spinout drugs, focusing on the unmet need for therapeutic needs in oncology.
Alan de Roth, CEO, ODD, said: “This latest funding will enable us to build and accelerate our successful computational design-led discovery focus. We are thrilled to be playing a key role in inventing oncological treatments that lead to better outcomes for cancer patients worldwide. ”
Rune Labs has launched a Portuguese subsidiary to improve diabetes care
Proper Neurology Software and Data Platform Company Rune Labs Lisbon has announced the formation of a team of Portugal-based lead designers.
The new team will focus on the features and workflow expansion of Rune Labs’ StrivePD ecosystem for Parkinson’s care. The subsidiary will also be Rune’s first permanent presence in Europe.
Will Newby, VP of the product, Rune Labs, says: “Rune Labs focuses on activating human-centered care for people living in Parkinson’s, and the Portuguese team of product designers will ensure that patients, physicians and researchers have a voice among us. Product. “
Babylon GP has opened two new clinics in London
Babylon GP at Hand has opened two new clinics in London that will provide patients with digital-first integrated care as well as face-to-face appointments.
The first clinic on Dean Farrer Street in Victoria opened last week and will open next month on Drummond Street in Easton.
Dr Matthew Noble, UK Medical Director, Babylon, said: “In addition to the highly accessible digital appointments, personal care is very important and we are really excited to launch these two new clinics for hand patients Babylon GP in London.”
CDP Venture Capital has launched Digital Health Startup Accelerator
CDP Venture Capital Sgr Announcing the launch of an accelerator for digital health startups focusing on innovative solutions for respiratory diseases, ophthalmology, women’s health, rare diseases and chronic pain management.
The VITA program is set up with Healthware Group and Danish Accelerator Accelerators with a total management of 6.35 million euros.
Roberto Assion, CEO and founder of Healthware Group, said: “The Vita Accelerator is a testament to Healthware’s commitment to contributing to the transformation of digital health, helping to grow and develop the most promising startups.”
The application is open To Italian startups and international startups willing to set up a registered office in Italy by June 12.
Clinical trials show that blood tests can detect 79% of early-stage bowel cancer
A primary care clinical trial in West Wales found that blood tests were able to detect 79% of early-stage bowel cancer and 100% of advanced bowel cancer.
Raman Spectrometry (RS) Blood Test was developed by Swansea University Spin-Out CancellationWith funding from Cancer Research Wales and Health and Care Research Wales.
Kansens has also secured 2 1.2 million from the National Institutes of Health and Care Research (NIHR) to further improve blood tests for use in clinical practice across Wales.
Dr. Ceres Jenkins, co-founder and director of Kansense, said: “If this test is available at the trigen stage, time and money will be saved, but most importantly, it will save patients from anxiety and unnecessary diagnostic tests.”
AI Cancer Diagnostic Company Wins Life Science Innovation Award
British AI startup Behold.AI Prix wins Best UK Digital Health Solutions at Gallian Awards.
The firm was rewarded for its Red Dot: Clinical Analysis software for X-ray detection of lung cancer, which is used on several NHS hospital sites as part of an independent validation on patient data.
Simon Russellingham, CEO and Chairman, Behold.AI, said: “The peer-reviewed evidence we have created shows that if we introduce this technology nationally, we can add the equivalent of 233 NHS consulting radiologists, equivalent to 255,000. Hours of consultation time each year. ”